Hepatitis C Treatment Snapshots: Daclatasvir

Hepatitis C Treatment Snapshots: Daclatasvir

For a simplified snapshot from TREAT Asia/amfAR on daclatasvir, a second generation direct-acting antiviral for the treatment of hepatitis C, please click here.

/ News

Share the Post

Related Posts

Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
Support letter for inclusion of Daclatasvir on 4th March, 2015.
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
18 hospitals offer free DAA therapy for treatment of Hepatitis C in Malaysia